GV Research Platform
GV Research Platform is a Hyderabad-based preclinical contract research organization founded in 2020, providing GLP-compliant pharmacology, toxicology, safety assessment, and medical device testing services to pharmaceutical, biotech, medical device, and agritech clients across India, augmented by exclusive distribution of global research tools.
- Company typePrivate
- Founded2020
- HeadquartersHyderabad, India
- Headcount51–100
- GTM typeB2B
- OfferingServices
What GV Research Platform does
GV Research Platform (GVRP) is an integrated life sciences R&D platform and preclinical contract research organization (CRO) founded in 2020 and headquartered in Hyderabad, India. The company provides non-clinical research services including pharmacology, regulatory toxicology, safety assessment, analytical and bioanalytical testing, medical device biocompatibility testing (ISO 10993), immunogenicity studies, food and feed additive safety, and ecotoxicity assessment to pharmaceutical, biotechnology, medical device, agritech, and specialty chemicals clients. GVRP also distributes research products in India as an authorized partner of multiple international providers, including SPF research models and Teklad lab animal diets (Envigo), iPSC-derived cell lines (Nexel), primary hepatocytes (BeCytes), oncology screening platforms and PDX models (Crown Bioscience), the GARD sensitization assay suite (SenzaGen), humanized mice models (Biocytogen), and antibody discovery services (Yurogen).
The company operates from a 35,000 sq ft AAALAC International and OECD GLP-compliant flagship preclinical research center in Hyderabad's Genome Valley cluster, supported by a 2,000+ sq ft temperature/humidity-controlled warehouse for Teklad diet distribution and a 15,000 sq ft GSRC Centre of Excellence for formulations R&D jointly established with Steps Biosciences in Bengaluru's Lifescapes cluster in June 2026. Its subsidiary GV Safety Assessment Platform (GVSAP) focuses on safety assessment, and the company holds multiple sector accreditations including AAALAC International, OECD GLP, NGCMA GLP, NABL, ISO 9001:2015, CPCSEA, and ISO 10993 capability.
GVRP's business model combines project-based professional services revenue (CRO contracts with study-fee pricing) with distribution revenue from authorized resale of international research products. The go-to-market is direct enterprise field sales for services combined with channel/reseller distribution for products. The company serves 85+ clients with a team of 100+ members led by Co-Founder & CEO Kalyan Korisapati and CGO & Co-Founder Anirudh Srinivasan, supported by a Board-Certified Toxicologist (DABT/ERT) as VP. The platform integrates in-house expertise with seven international partnerships to provide single-point access to global research tools for the Indian ecosystem.
GV Research Platform firmographics
Firmographics- Name
- GV Research Platform
- Legal name
- GV Research Platform
- Website
- https://gvrp.in
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- GV Research Platform is a Hyderabad-based preclinical contract research organization founded in 2020, providing GLP-compliant pharmacology, toxicology, safety assessment, and medical device testing services to pharmaceutical, biotech, medical device, and agritech clients across India, augmented by exclusive distribution of global research tools.
- Ownership category
- akta.pro rank
GV Research Platform industry classification
Industry- Product category
- Preclinical Contract Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB)
- akta.pro secondary industries
- Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC), Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD), Laboratory Quality & GLP/GCLP Compliance (HLAGAKAK)
Keywords
Where GV Research Platform is headquartered
LocationHeadquarters
- HQ city
- Hyderabad
- HQ country
- India
- HQ region
- Asia
Offices4 records
Markets served
GV Research Platform business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Contract Research Services: Project-based preclinical research contracts providing pharmacology, toxicology, bioanalytical, and safety assessment services to pharmaceutical, biotech, medical device, agritech, and specialty chemicals companies. Revenue generated through study fees, with pricing based on study complexity, species, and regulatory requirements.
- Research Products Distribution: Authorized distributor of international research products in India including SPF animal models (Envigo), Teklad® lab animal diets, iPSC-derived cell lines (Nexel), primary hepatocytes (BeCytes), and specialty assays. Products sold directly to research institutions and pharmaceutical companies.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Rodent Diets - 2014C (14% Protein maintenance) |
| Unit Pricing | Pay-as-you-go | Rodent Diets - 2018C (18% Protein breeding/maintenance) |
| Unit Pricing | Pay-as-you-go | Rabbit Diet - 2031C (High Fibre) |
| Unit Pricing | Pay-as-you-go | Guinea Pig Diet - 2041C (Vitamin C fortified) |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels5 records
GV Research Platform product offering
Product offeringCore offering
GVRP operates an integrated preclinical contract research organization (CRO) delivering non-clinical research services including pharmacology, regulatory toxicology, analytical and bioanalytical testing, safety assessment, immunogenicity studies, medical device biocompatibility testing (ISO 10993), and food/feed additive assessment. The platform also functions as an authorized India distributor for international research product lines including SPF rodent models, Teklad laboratory diets, iPSC-derived cell lines, primary hepatocytes, humanized mice models, oncology screening platforms, and genomic biomarker assays. Services are executed at two GLP-compliant facilities: a 35,000 sq ft flagship center in Hyderabad's Genome Valley and a 15,000 sq ft formulations R&D center in Bengaluru.
Product overview
GV Research Platform (GVRP) is an integrated life sciences R&D platform offering a comprehensive portfolio of preclinical research services and biological products. The core platform provides research services including Pharmacology, Analytical & Bioanalytical Testing, Regulatory Toxicology, and Safety Assessment, complemented by research products such as SPF Research Models, Biological Samples, and Teklad® Diets. GVRP extends its capabilities through exclusive partnerships with global technology providers: Crown Bioscience for oncology platforms (OmniScreen™ and MuScreen™); SenzaGen for the GARD® allergenicity assay suite; Yurogen Biosystems for antibody discovery; Nexel for iPSC-derived cells (Cardiosight®, Hepatosight®, Neurosight®); BeCytes for primary hepatocytes; Biocytogen for humanized mouse models; and Envigo for SPF models and Teklad® diets. The company operates R&D centers in Hyderabad (35,000 sq. ft.) and Bengaluru (15,000 sq. ft.), providing end-to-end solutions from early discovery through regulatory submission for pharmaceutical, biotechnology, medical device, and agrochemical industries.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmacology In vitro and in vivo pharmacology studies including high-throughput screening, mechanistic studies, disease-specific animal models, and customized study designs for efficacy and pharmacokinetic assessment. Targeted at pharmaceutical and biotechnology companies requiring preclinical efficacy data.
- Analytical & Bioanalytical Testing Method development and validation, bioanalysis, ADME/PK studies, dose formulation analysis, stability studies, and extractables/leachable analysis for pharmaceutical, biological, agrochemical, and medical device products. Targeted at developers requiring quantitative bioanalytical support for IND/NDA submissions.
- Regulatory Toxicology Comprehensive toxicology testing including exploratory and GLP-certified studies for pharmaceuticals, biologics, vaccines, agrochemicals, and medical devices, with regulatory submission support. Targeted at sponsors requiring IND-enabling and product registration toxicology data.
- Safety Assessment Preclinical safety evaluation including IND-enabling studies, in vivo toxicology, in vitro safety testing, and regulatory support for FDA, EMA, and global submissions. Targeted at pharmaceutical and biotechnology companies preparing global regulatory filings.
- Immunogenicity & Immunotoxicity Studies Comprehensive evaluation of immune responses to biologics, vaccines, and cell and gene therapies including immune organ analysis, cytokine profiling, and hypersensitivity assessments in preclinical models. Targeted at developers of biologics, vaccines, and advanced therapies requiring immunogenicity characterization for IND submissions.
- Medical Device Testing ISO 10993 biocompatibility testing services including cytotoxicity, sensitization, irritation, pyrogenicity, genotoxicity, implantation, and hemocompatibility for regulatory submissions to CDSCO, US FDA, and EU MDR. Targeted at medical device manufacturers (Class I, II, III) requiring biological safety evaluation for product registration.
- Food & Feed Additives Testing End-to-end preclinical assessment for food and feed additives including ingredient characterization, safety and toxicological evaluation, microbiological testing, and GLP-aligned study conduct. Targeted at food/feed additive and agritech companies requiring regulatory safety data.
- Ecotoxicity Assessment Services Environmental toxicity evaluation services for agrochemical and industrial chemical products including bioassays, field studies, and environmental fate modeling to support regulatory compliance. Targeted at agritech and specialty chemical companies needing ecotoxicity data for product registration.
- SPF Research Models SPF rodent models including immunocompromised strains (NOD scid, SCID beige, Athymic Nude) and traditional strains (C57BL/6, BALB/c, Sprague Dawley, Wistar Han, ICR), bred in partnership with Envigo RMS LLC under harmonized global standards. Targeted at pharmaceutical R&D and academic research institutions requiring reproducible animal models for preclinical studies.
- Biological Samples High-quality plasma, serum, and organ samples from validated rodent models (Sprague Dawley, Wistar Han, C57BL/6, Balb/c, athymic nude, SCID/beige, NOD.SCID) with custom tissue preparation options. Targeted at researchers needing validated biological matrices for assay development and bioanalysis.
- Teklad Laboratory Animal Diets Premium laboratory animal diets from Envigo (Teklad line) including rodent formulations 2014C (14% protein maintenance), 2018C (18% protein breeding and maintenance), autoclaved 2018SC, rabbit 2031C (high fibre), and guinea pig 2041C (Vitamin C fortified), distributed in India under temperature/humidity controlled warehousing with same-day dispatch. Targeted at animal research facilities and academic institutions across India.
- Human iPSC-Derived Cell Lines Nexel's iPSC-derived products including Cardiosight-S (cardiomyocytes), Hepatosight-S (hepatocytes), and Neurosight-S (neurons), distributed in India for drug discovery, toxicity testing, disease modeling, and regenerative medicine. Targeted at pharmaceutical R&D and academic researchers requiring validated human iPSC-derived cells.
- Primary Hepatocytes BeCytes Biotechnologies' primary human and animal hepatic cells including plateable and suspension hepatocytes, non-parenchymal cells (stellate cells, liver endothelial cells, Kupffer cells), and NASH hepatocytes, distributed in India. Targeted at ADME/PK researchers and pharmaceutical hepatotoxicity programs.
- Humanized Mice Models Biocytogen humanized mouse models including immune-checkpoint, cytokine, and GPCR models, plus engineered cell lines for preclinical drug evaluation, accessible through GVRP as the India channel partner. Targeted at immuno-oncology and infectious disease researchers in India.
- OmniScreen Oncology Screening Service Crown Bioscience's high-throughput oncology screening service for multiple drug compounds across diverse cancer cell line panels (OmniPanel 520+ lines, XenoSelect 210+ xenograft-bearing lines, PrimePanel 30+ primary PDX-derived lines) with integrated bioinformatics (dose-response curves, inhibition heat maps, RNAseq). Targeted at oncology drug developers seeking large-scale in vitro screening.
- MuScreen Immunotherapy Screening Crown Bioscience's in vivo immunotherapy screening platform using MuPrime syngeneic models and tumor homograft models for mechanism-of-action and efficacy evaluation in immunocompetent hosts. Targeted at immuno-oncology developers running preclinical immunotherapy efficacy studies.
- Oncology & Immuno-Oncology Drug Development Access to Crown Bioscience's comprehensive oncology services including in vitro platforms (2D cell lines, HuCell, CRISPR/Cas9 models, organoids) and in vivo pharmacology using PDX models, offered through GVRP in India. Targeted at oncology drug developers requiring PDX-based efficacy studies.
- Allergenicity Assessment (GARD Assay Suite) GARD assay suite from SenzaGen including GARDskin (OECD TG 442E approved for skin sensitization), GARDpotency (potency classification), GARDair (respiratory sensitization), and GARDskin Medical Device (ISO 10993 biocompatibility) using genomic biomarker signatures. Targeted at cosmetic, chemical, and medical device manufacturers needing in vitro alternative sensitization testing.
- Antibody Discovery Solutions Yurogen Biosystems' SMab single B-cell platform for antibody discovery from multiple host species (rabbit, mouse, human, camelid) including recombinant expression and SPR-based bioanalytical services. Targeted at biologics developers in India seeking advanced antibody discovery and engineering capabilities.
Quantifiable outcome
- India's bioeconomy exceeding USD 165 billion with 10,000+ biotech startups supports market opportunity for preclinical CRO services
- +1 more outcomes
Companies that use GV Research Platform
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
GV Research Platform technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature5 records
GV Research Platform partnerships and signals
Strategic signalPartnerships
Ten partnerships are on record, tiered core.
- Steps BiosciencescoreJoint establishment of GSRC Center of Excellence for formulations research and development within the Lifescapes life sciences cluster in Bengaluru. Facility purpose-built to address complex formulation challenges including drug delivery systems, sterile injectables, and differentiated dosage forms. Represents GVRP's strategic expansion into high-complexity formulations.
- Yurogen BiosystemscorePartnership to enhance biologics drug discovery in India. Yurogen provides advanced antibody discovery, engineering, and bioanalytical services using proprietary SMab™ single B-cell platform for antibody generation from multiple host species including rabbit, mouse, human, and camelid. GVRP enables researchers in India to access these services.
- BiocytogencoreExpanded strategic partnership between GV Safety Assessment Platform (GVSAP) and Biocytogen to enhance India's biopharma ecosystem. Strengthened alliance encompasses pharmaceutical services and licensing for gene-edited cell lines supporting research from target validation to pharmacological evaluation. CEOs of both companies highlighted partnership's role in facilitating precision-driven drug discovery in India's rapidly evolving biopharma sector.
- BeCytes BiotechnologiescorePartnership to advance biopharma research in India through primary liver cell-based products. BeCytes (headquartered in Barcelona, Spain) specializes in human tissue procurement, cell isolation, and cell-based solutions for in vitro models. GVRP is authorized distributor for hepatic cell products including fresh and cryopreserved plateable human and animal hepatic cells.
- SenzaGencorePartnership to transform safety assessment practices in India. GVRP authorized distributor of SenzaGen's GARD® assay suite including GARD®skin (OECD approved for skin sensitization), GARD®potency, GARD®air (respiratory sensitization), and GARD®skin Medical Device for ISO 10993 biocompatibility testing.
- NexelcorePartnership to bring cutting-edge iPSC technology to India's biomedical community. Nexel (South Korea) manufactures iPSC-derived cardiomyocytes (Cardiosight®-S), hepatocytes (Hepatosight®-S), and neurocytes (Neurosight®-S) for drug discovery, toxicity testing, disease modeling, and regenerative medicine.
- Crown BiosciencecorePartnership announced for Crown Bioscience services in India. Crown Bioscience is global CRO headquartered in San Diego with operations in 10 global locations. Expertise in oncology, immuno-oncology with tumor organoid services (HUB technology) and world's largest commercially available PDX collection.
- Envigo RMS LLC (Inotiv)corePartnership for Indian market enabling access to Envigo research models. Envigo RMS LLC is a global leader in research model breeding and distribution providing high-quality branded models and Teklad® diets for preclinical research.
- Crown BiosciencecoreAuthorized distributor for Crown Bioscience oncology services in India. Provides access to OmniScreen™ (high throughput oncology screening), MuScreen™ (in vivo immunotherapy screening), PDX models (world's largest collection), and Indivumed Services for biobank products and liquid biopsy samples.
- Envigo RMS LLC (Inotiv)coreExclusive breeding partner and authorized distributor of Envigo SPF research models in India. Provides access to branded Envigo research models including immunocompromised, traditional, and outbred rodent strains. Breeding program harmonized with Envigo global standards with veterinary team ensuring animal welfare and reproducibility.
Scale indicators8 records
Recent moves7 records
Expansion highlights6 records
GV Research Platform competitors and assessment
Company assessmentDirect peers
- Syngene International: Bengaluru-based, publicly listed integrated CRO/CDMO offering preclinical safety, toxicology, bioanalytical and formulation services to global pharma. Closest Indian peer to GVRP in service mix, regulatory credentials, and client base.
- Sai Life Sciences: Hyderabad-based contract research and manufacturing organization providing drug discovery, preclinical toxicology, and bioanalytical services. Direct competitor to GVRP in Indian preclinical safety assessment, headquartered in the same Genome Valley cluster.
- Piramal Pharma Solutions: India-headquartered CRO/CDMO with preclinical, analytical and manufacturing services. Overlaps with GVRP in safety assessment, bioanalytical testing and medical-device-related testing for global pharma sponsors.
- Anthem Biosciences: Bengaluru-based integrated CRO offering drug discovery, preclinical pharmacology and toxicology services. Direct Indian preclinical competitor with comparable therapeutic-area breadth and GLP capability.
- Bioneeds India: Bengaluru-based preclinical CRO specializing in GLP toxicology, safety pharmacology and medical device testing under OECD-GLP and AAALAC frameworks. Direct Indian niche competitor, especially for medical device biocompatibility work.
- Jubilant Biosys: Bengaluru-based discovery and preclinical CRO offering in vitro/in vivo pharmacology and toxicology services. Comparable in offering integrated discovery-through-preclinical solutions to global biopharma.
- Vivo Bio Tech: Hyderabad-based preclinical CRO offering toxicology, pharmacology and animal model services with OECD-GLP accreditation. Closely comparable Indian preclinical peer in scale, location and service profile.
Broad incumbents
- WuXi AppTec: China-based global CRO/CDMO with the largest preclinical and toxicology capacity in Asia. Comparable in preclinical service breadth but at vastly larger scale; competes for the same outsourcing-from-India sponsors.
- Charles River Laboratories: Global preclinical CRO leader offering toxicology, safety assessment, research models and bioanalytical services. Sets the global benchmark for GLP toxicology and is the principal incumbent GVRP competes against for Indian and global sponsor contracts.
- Labcorp Drug Development: Global CRO (formerly Covance) with extensive preclinical toxicology, bioanalytical and central-lab capabilities. Competes for the same global pharma preclinical outsourcing budgets that GVRP targets.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
GV Research Platform social profiles
Digital presenceGV Research Platform compliance and trust
Trust signalCompliance7 records
GV Research Platform financial estimates
Financial estimateRevenue estimate
Valuation estimate
GV Research Platform leadership team
Management profileNumber of profiles
Profiles7 records
GV Research Platform subsidiaries and ownership
Company hierarchySubsidiaries2 records
GV Research Platform funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
GV Research Platform M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about GV Research Platform
What does GV Research Platform do?
GVRP operates an integrated preclinical contract research organization (CRO) delivering non-clinical research services including pharmacology, regulatory toxicology, analytical and bioanalytical testing, safety assessment, immunogenicity studies, medical device biocompatibility testing (ISO 10993), and food/feed additive assessment. The platform also functions as an authorized India distributor for international research product lines including SPF rodent models, Teklad laboratory diets, iPSC-derived cell lines, primary hepatocytes, humanized mice models, oncology screening platforms, and genomic biomarker assays. Services are executed at two GLP-compliant facilities: a 35,000 sq ft flagship center in Hyderabad's Genome Valley and a 15,000 sq ft formulations R&D center in Bengaluru.
Is GV Research Platform a public or private company?
GV Research Platform is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was GV Research Platform founded?
GV Research Platform was founded in 2020. It employs 51 to 100 people.
Where is GV Research Platform based?
GV Research Platform is headquartered in Hyderabad, India, in the Asia region.
How does GV Research Platform make money?
Two revenue lines are on record. Contract Research Services are the primary driver. The others are research Products Distribution.
Who are GV Research Platform's main competitors?
Direct peers on record are Syngene International, Sai Life Sciences, Piramal Pharma Solutions, Anthem Biosciences, Bioneeds India, Jubilant Biosys and Vivo Bio Tech. Broad incumbents are WuXi AppTec, Charles River Laboratories and Labcorp Drug Development.
Does GV Research Platform have an API?
No public API is recorded for GV Research Platform.
What industry is GV Research Platform in?
GV Research Platform's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK), with a secondary code of HLAGAAAC, Toxicology & Safety Assessment CROs (GLP). Its NAICS code is 541714 and its SIC code is 8731.